Drug Research
Drug Delivery

Drug Delivery

Mundipharma agrees to distribute Grünenthal's pain-relief drug in China Mundipharma has agreed to market and distribute Grünenthal’s Tramal (tramadol) in China from 1 May 2018.
Drug Research > Drug Delivery > News
e-Therapeutics signs two collaboration deals to enhance AI technology capabilities By PBR Staff Writer
UK-based drug developer e-Therapeutics has agreed to collaborate with Intellegens and Biorelate to improve and extend its artificial intelligence (AI) technology capabilities.
Drug Research > Drug Delivery > News Charles River acquires UK CRO KWS BioTest By PBR Staff Writer
Charles River Laboratories International has acquired UK-based contract research organization (CRO) KWS BioTest for about £15m.
Drug Research > Drug Delivery > News
See more Drug Delivery news

Latest Drug Delivery News and Insight

View all Drug Delivery news or find news targeted to your interests
Mallinckrodt agrees to sell hemostasis products to Baxter
Mallinckrodt has agreed to divest several hemostasis products to Baxter International for about $185m, with upfront payment of $153m, inclusive of existing inventory, and the remainder in potential future milestones
Drug Research > Drug Delivery > News
Recipharm to buy remaining stake in Nitin Lifesciences
Recipharm has agreed to acquire the remaining 26% stake in Nitin Lifesciences, which were owned by members of the founding Sobti family.
Drug Research > Drug Delivery > News
Mylan launches Estrace Cream generic after FDA approval
Mylan has launched Estradiol Vaginal Cream USP, 0.01%, the first generic version of Allergan's Estrace Cream, in the US.
Drug Research > Drug Delivery > News
Evox Therapeutics to collaborate with Boehringer Ingelheim on exosome-mediated drug delivery
Evox Therapeutics has entered into a research collaboration with Boehringer Ingelheim to investigate exosome-mediated delivery of RNAs with high medical relevance to targets for specific disease areas of focus to Boehringer Ingelheim.
Drug Research > Drug Delivery > News
NICE says lenvatinib should be available on NHS
The National Institute for Health and Care Excellence (NICE) has announced that lenvatinib should be available on the National Health Service (NHS) to give people with advanced kidney cancer a new treatment option.
Drug Research > Drug Delivery > News
Report expects global cryotherapy market to cross $4bn by 2024
A new report from Persistence Market Research expects worldwide cryotherapy market to exceed $4bn by 2024.
Drug Research > Drug Delivery > News
Lohmann Therapy System (LTS) - Transdermal Therapeutic Systems and Oral Thin Films
LTS is the market leader in alternative drug delivery systems, in the form of transdermal therapeutic systems and oral thin films. We develop and manufacture drug delivery systems that offer patients reliable therapeutic efficacy with total comfort and convenience.
Drug Research > Drug Delivery > Suppliers
View all Drug Delivery news or find news targeted to your interests